Home
Clinical Trials
Partnerships
Contact Us
News & Resources
Careers
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Disease
Oncology
Our Product
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Publications
Early/Expanded Access Policy
Our Science
Investors
Press Releases
Events and Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Diseases
Oncology
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Publications
Early/Expanded Access Policy
Our Product
Our Science and Technology
News and Resources
News
Posters
Publications
Videos
Investors
Press Releases
Company Information
Corporate Governance
Events and Presentations
SEC Filings
Stock Information
Careers
Partnerships
Contact Us
Search our website
Conferences
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
August 28th, 2018
VBI Vaccines to Present at the Canaccord Genuity 38th Annual Growth Conference
August 6th, 2018
VBI Vaccines to Participate in the 2018 Oppenheimer Boston Oncology Insight Summit
July 9th, 2018
VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference
June 19th, 2018
VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine
May 10th, 2018
VBI Vaccines to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
December 12th, 2017
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017
November 10th, 2017
VBI Vaccines Hepatitis B Data Selected as Presidential Poster of Distinction at The Liver MeetingĀ® 2017
October 17th, 2017
VBI Vaccines to Present at September 2017 Investor Conferences
September 12th, 2017
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at the Immuno-Oncology Summit
August 28th, 2017
VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine
July 27th, 2017
VBI Vaccines Announces Phase 3 Clinical Program for Sci-B-VacĀ® Hepatitis B Vaccine
July 11th, 2017
VBI Vaccines to Present at Jefferies 2017 Global Healthcare Conference
June 5th, 2017
VBI Vaccines to Present Updates on Multiple Programs at the World Vaccine Congress
April 5th, 2017
VBI Vaccines to Present at the Immunization and Vaccine Summit
December 5th, 2016
VBI Vaccines to Present at the Society of Neuro-Oncology Annual Meeting
November 10th, 2016
VBI Vaccines to Present Zika Vaccine Program Poster at the Keystone Symposia on Translational Vaccinology for Global Health
October 27th, 2016
VBI Vaccines to Present at the World Vaccine Congress Europe
October 5th, 2016
VBI Vaccines to Present at the Ladenburg Thalmann Healthcare Conference
September 26th, 2016
VBI Vaccines to Present at the Rodman & Renshaw Annual Global Investment Conference
September 7th, 2016
Page 3 of 5
‹
1
2
3
4
5
›
Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI
Sign Up Now